|
|
Vision - 49 CFR 391.41(b)(10) |
Ophthalmic Preparations
|
|
Determine if the treatment is having the desired effect of preserving vision that meets qualification requirements without any visual and/or systemic side effects that interfere with safe driving (e.g., stinging, blurring, decreased night vision, sensitivity to glare, headache, or allergic reaction).
Categories include:
|
|
|
|
Classifications of agents used to treat age-related macular degeneration include:
- Antioxidants and zinc.
- Vascular endothelial growth factor (VEGF) inhibitors.
|
|
|
|
Classifications of anti-allergy agents used to treat allergic conjunctivitis include:
- Oral and topical antihistamines.
- Topical decongestants.
- Antihistamine/decongestant combinations.
- Mast cell stabilizers.
- Topical nonsteroidal anti-inflammatory.
|
|
|
|
Classifications of agents used to treat glaucoma include:
- Prostaglandin analogs.
- Beta adrenergic blocking agents.
- Carbonic anhydrase inhibitors.
- Alpha agonists.
- Cholinergic agonists.
- Osmotic agents.
- Combinations.
|
|
|
|
Classifications of anti-infective agents used to treat bacterial conjunctivitis include oral and topical antibiotics.
|
|
|
|
Classifications of agents used to treat dry eyes include:
- Lubricants.
- Nonsteroidal anti-inflammatory.
- Topical cyclosporine.
|